Canada to India: Diagnostic Import Trade Route

The Canada to India Diagnostic corridor is one of India's established pharmaceutical import routes from Canada, with 155 shipments documented worth a combined $447.2K USD. The route is dominated by ARTRON BIORESEARCH INC. , which alone accounts for roughly 24% of all import value, reflecting the consolidated nature of Canada's diagnostic export sector.

Across 18 active Canada suppliers, the average shipment value stands at $2.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with diagnostic's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 10.8%, placing it at rank #16 among India's top diagnostic import origins globally.

On the Indian buyer side, key Indian importers include MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED , TULIP DIAGNOSTICS PRIVATE LIMITED , TULIP DIAGNOSTICS PRIVATE LIMITED and 13 others. MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED is the single largest Indian importer with 52 shipments valued at $116.1K USD.

India's diagnostic imports from Canada are driven primarily by a handful of large-scale Canada manufacturers. ARTRON BIORESEARCH INC. with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — Indian buyers benefit from Canada supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ARTRON BIORESEARCH INC. , ARTRON BIO RESEARCH INC , ARTRON BIORESEARCH INC. — together account for 62% of total trade value on this route. The average shipment value of $2.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ab02-07-c1 anti hbsag mcab for coating (reagent) (list3 sr.no.123 for mfg diagnostics kit of hepatitis b antigen) and a27-ab1 monoclonal anti hbsag antibody (diagnostic agent fordetection of hepatitis b antigen), 2500 mg [list 3 s/n 123]a27-ab1 monoclonal anti hbsag antibody (diagnostic agent for, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Canada supplier.

On the buying side, MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED is the largest importer with 52 shipments worth $116.1K USD — representing 26% of all diagnostic imports from Canada on this route. A total of 16 buyers are active on this corridor.